Nearly half the voting members of a Department of Health and Human Services linkurl:stem cell;http://www.the-scientist.com/article/display/54071/ advisory council have financial conflicts of interest despite the committee's pledge to limit these types of conflicts, according to a linkurl:survey;http://www.cspinet.org/integrity/watch/200804281.html#1 conducted by a science watchdog group. The Center for Science in the Public Interest polled the 25 voting members of HHS's linkurl:Advisory Council on Blood Stem Cell Transplantation;http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html (ACBSCT) and found that 11 reported having financial ties to stem cell and linkurl:umbilical cord blood;http://www.the-scientist.com/2007/03/01/s62/1/ banking companies, drug makers, and the linkurl:transplantation;http://www.the-scientist.com/article/display/17367/ industry. For example, linkurl:Frederick Appelbaum,;http://myprofile.cos.com/APPELBAUM who is the head of medical oncology at the University of Washington, has relationships with Merck, Bristol-Myers Squibb, Wyeth, and Genzyme. Another council member, linkurl:Richard Champlin,;http://www.mdanderson.org/departments/bmt/display.cfm?id=627c8063-8efd-11d4-80fa00508b603a14&method=displayfull&pn=d1766775-8e4c-11d4-80fa00508b603a14 is the chairman of the University of Texas in Houston's Stem Cell Transplantation and Cellular Therapy Department, but also serves on the medical advisory board of linkurl:Stemcyte,;http://www.the-scientist.com/article/display/15348/ an international company that runs...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
